NO971376D0 - N-substituerte piperidinyl bisykliske benzoatderivater - Google Patents

N-substituerte piperidinyl bisykliske benzoatderivater

Info

Publication number
NO971376D0
NO971376D0 NO971376A NO971376A NO971376D0 NO 971376 D0 NO971376 D0 NO 971376D0 NO 971376 A NO971376 A NO 971376A NO 971376 A NO971376 A NO 971376A NO 971376 D0 NO971376 D0 NO 971376D0
Authority
NO
Norway
Prior art keywords
6alkyl
substituted
halo
hydrogen
alk
Prior art date
Application number
NO971376A
Other languages
English (en)
Other versions
NO971376L (no
NO313238B1 (no
Inventor
Georges Henri Paul Van Daele
Jean-Paul Rene Marie A Bosmans
Frans Maria Alfons Van Keybus
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO971376D0 publication Critical patent/NO971376D0/no
Publication of NO971376L publication Critical patent/NO971376L/no
Publication of NO313238B1 publication Critical patent/NO313238B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19971376A 1994-09-27 1997-03-24 N-substituerte piperidinyl bisykliske benzoatderivater NO313238B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94202792 1994-09-27
US45548695A 1995-05-31 1995-05-31
PCT/EP1995/003691 WO1996010027A1 (en) 1994-09-27 1995-09-19 N-substituted piperidinyl bicyclic benzoate derivatives

Publications (3)

Publication Number Publication Date
NO971376D0 true NO971376D0 (no) 1997-03-24
NO971376L NO971376L (no) 1997-05-05
NO313238B1 NO313238B1 (no) 2002-09-02

Family

ID=26136613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971376A NO313238B1 (no) 1994-09-27 1997-03-24 N-substituerte piperidinyl bisykliske benzoatderivater

Country Status (23)

Country Link
EP (1) EP0784620B1 (no)
JP (1) JP3953097B2 (no)
CN (1) CN1068880C (no)
AT (1) ATE187453T1 (no)
AU (1) AU699152B2 (no)
BR (1) BR9509036A (no)
CA (1) CA2200578C (no)
CZ (1) CZ289031B6 (no)
DE (1) DE69513846T2 (no)
DK (1) DK0784620T3 (no)
ES (1) ES2141383T3 (no)
FI (1) FI119640B (no)
GR (1) GR3032646T3 (no)
HU (1) HU218698B (no)
IL (1) IL115413A (no)
MY (1) MY113202A (no)
NO (1) NO313238B1 (no)
NZ (1) NZ293605A (no)
PL (1) PL182502B1 (no)
PT (1) PT784620E (no)
RU (1) RU2154064C2 (no)
WO (1) WO1996010027A1 (no)
ZA (1) ZA958081B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058527A2 (en) * 1998-05-14 1999-11-18 EGIS Gyógyszergyár Rt. Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide
CA2551171C (en) 2003-12-23 2012-07-10 Bio-Medisinsk Innovasjon As Modulators of peripheral 5-ht receptors
NZ551603A (en) 2004-06-24 2010-11-26 Incyte Corp N-substituted piperidines and their use as pharmaceuticals
SI2395002T1 (sl) 2005-11-08 2014-10-30 Vertex Pharmaceuticals Incorporated Farmacevtski sestavek, vsebujoč heterociklični modulator prenašalcev z ATP-vezavno kaseto
JP5497633B2 (ja) 2007-05-09 2014-05-21 バーテックス ファーマシューティカルズ インコーポレイテッド Ｃｆｔｒのモジュレーター
WO2009073757A1 (en) 2007-12-07 2009-06-11 Vertex Pharmaceuticals Incorporated Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
AU2008335440B2 (en) 2007-12-07 2013-11-07 Vertex Pharmaceuticals Incorporated Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
US8299099B2 (en) 2008-02-28 2012-10-30 Vertex Pharmaceuticals Incorporated Heteroaryl derivatives as CFTR modulators
WO2011127241A2 (en) 2010-04-07 2011-10-13 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
PL2555754T3 (pl) * 2010-04-07 2016-09-30 Formy stałe kwasu 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-ilo)cyklopropanokarboksyamido)-3-metylopirydyn-2-ylo)benzoesowego
WO2015073231A1 (en) 2013-11-12 2015-05-21 Vertex Pharmaceuticals Incorporated Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases
WO2016081556A1 (en) 2014-11-18 2016-05-26 Vertex Pharmaceuticals Incorporated Process of conducting high throughput testing high performance liquid chromatography

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
RU2154064C2 (ru) 2000-08-10
GR3032646T3 (en) 2000-06-30
HU218698B (hu) 2000-11-28
NZ293605A (en) 1998-07-28
ES2141383T3 (es) 2000-03-16
MY113202A (en) 2001-12-31
IL115413A0 (en) 1995-12-31
NO971376L (no) 1997-05-05
NO313238B1 (no) 2002-09-02
JP3953097B2 (ja) 2007-08-01
FI971274A (fi) 1997-03-26
FI971274A0 (fi) 1997-03-26
CN1166171A (zh) 1997-11-26
HUT77173A (hu) 1998-03-02
BR9509036A (pt) 1997-10-14
IL115413A (en) 2000-02-17
ATE187453T1 (de) 1999-12-15
CA2200578A1 (en) 1996-04-04
EP0784620A1 (en) 1997-07-23
ZA958081B (en) 1997-03-26
CN1068880C (zh) 2001-07-25
AU3608195A (en) 1996-04-19
PL319997A1 (en) 1997-09-01
DE69513846D1 (de) 2000-01-13
FI119640B (fi) 2009-01-30
WO1996010027A1 (en) 1996-04-04
PT784620E (pt) 2000-05-31
CZ91897A3 (en) 1997-12-17
PL182502B1 (pl) 2002-01-31
DE69513846T2 (de) 2000-07-06
CZ289031B6 (cs) 2001-10-17
CA2200578C (en) 2006-11-07
AU699152B2 (en) 1998-11-26
MX9702363A (es) 1997-10-31
EP0784620B1 (en) 1999-12-08
JPH10506118A (ja) 1998-06-16
DK0784620T3 (da) 2000-05-22

Similar Documents

Publication Publication Date Title
ES449191A1 (es) Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina.
NO971376D0 (no) N-substituerte piperidinyl bisykliske benzoatderivater
TW369526B (en) Diazabicyclic neurokinin antagonists
DE69633607D1 (de) Piperidinderivate mit tachykinin-antagonistischer wirkung
ATE415436T1 (de) Polyhydroxyalkanoat
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
ATE171943T1 (de) Piperidin-verbindungen, ihre darstellung und ihre verwendung
BG104717A (en) Water soluble azoles as broad-spectrum antifungals
PL322872A1 (en) Novel triazolones - inhibitors of b apolipoprotein synthesis
HUP9801751A2 (hu) Benzopiránszármazékok, azok előállítása és alkalmazása, valamint ilyen származékokat tartalmazó gyógyszerkészítmények
TW360653B (en) A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
BG103395A (en) Derivatives of benzenesulphonamide and medicaments containing them
ATE178064T1 (de) Phenyl-oxo-alkyl-(4-piperidinyl) benzoatderivate
JO1648B1 (en) Nitrogen compounds
JO1697B1 (en) Pyridine derivatives
NO932513L (no) N-alkyl-kinuklidinium-salter

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees